Recent

% | $
Quotes you view appear here for quick access.

Impax Laboratories Inc. Message Board

  • dwinn2001 dwinn2001 Jan 21, 2013 8:53 AM Flag

    Typical FDA

    As always, getting better drugs or devices to sick people quickly is a low priority with the FDA. Yes, Rytary is a better drug and while you say you would make it at the Hayward plant, we aren't going to approve in case you make it at the Hayward plant.

    I bought shares in IPXL due to their financials and Rytary was just a plus. Even without Rytary, this is a very solid company and stock but this FDA decision is a little frustrating.

    Not sure what the FDA is trying to accomplish here.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IPXL
25.91+0.51(+2.01%)11:47 AMEDT